70 results on '"Jin, Lee-Way"'
Search Results
2. High‐density lipoprotein particle size distribution among patients with Alzheimer’s disease, mild cognitive impairment, and age‐matched controls
3. Neuropathology in the LifeAfter90 Study: 2023 update on an Ethnically Diverse Cohort Study of Oldest‐Old
4. The ketone body β‐hydroxybutyrate shifts microglial metabolism and suppresses amyloid‐β oligomer‐induced inflammation in human microglia
5. The role of FUT8 ‐catalyzed core fucosylation in Alzheimer's amyloid‐β oligomer‐induced activation of human microglia
6. Intraoperative detection of IDH ‐mutant glioma using fluorescence lifetime imaging
7. Plasma amyloid β 42/40 associations on episodic memory: Moderations with depressive symptoms and marital status
8. Neuropathology in the LifeAfter90 Study: Update on an Ethnically Diverse Cohort Study of Oldest‐Old
9. Validation and utility of plasma neurofilament light as a biomarker for vascular cognitive impairment
10. Alzheimer’s Disease Patients, Especially ApoE4 Carriers, Have Significantly Reduced High‐density Lipoprotein Particle Size Revealed by Negative‐stained Transmission Electron Microscopy
11. Amyloid‐β plus cholesterol treatment impairs the ability of microglia to efflux excess cholesterol
12. Altered HDL Cholesterol Efflux Capacity and LCAT Activity is APOE‐Specific in Alzheimer Disease and Mild Cognitive Impairment Patients
13. Plasma biomarkers predict cognitive trajectories in an ethnoracially and clinically diverse cohort: Mediation with hippocampal volume
14. Glycosylation alterations in serum of Alzheimer's disease patients show widespread changes in N ‐glycosylation of proteins related to immune function, inflammation, and lipoprotein metabolism
15. Brain‐region‐specific, glycosylation‐related transcriptomic alterations in Alzheimer's disease
16. Neuropathology in the LifeAfter90 study: A new ethnically diverse cohort study of oldest‐old
17. Efficacy of soluble epoxide hydrolase inhibition in a rat model of Alzheimer’s disease
18. HDL particle morphology in Alzheimer’s disease patients compared to healthy human subjects and chemically modified HDL
19. Identification of the neuroprotective Shc target in Alzheimer's and validation of the neuroprotective benefit of a set of small‐molecule Shc blockers
20. Association of plasma abeta and tau levels in relation to cognition and brain structure in a diverse community
21. A comparison of cerebral small vessel disease severity between autopsy cohorts in the northeast of England and Sacramento County in California, USA
22. Quantification of small vessel disease in frontal and parietal white matter, genu and splenium
23. Age‐related resident memory CD8 T cells link amyloid to NFTs and neurodegeneration in mice and are modulated in AD and MCI blood
24. Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4-mediated calcium entry in microglia
25. Concomitant Improvement of Synaptic Decline and NASH using Fermentable Fiber Inulin
26. Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
27. Multisite study of the relationships between antemortem [11C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
28. The voltage‐gated potassium channel Kv1.3 is required for microglial pro‐inflammatory activation in vivo
29. IC‐P‐057: HEAD‐TO‐HEAD COMPARISON OF PIB AND FDG‐PET IN AUTOPSY‐CONFIRMED CASES
30. P4‐037: THE USE OF CONVOLUTIONAL NEURAL NETWORKS TO QUANTIFY AMYLOID PLAQUES IN POSTMORTEM HUMAN BRAIN
31. O4‐09‐02: HEAD‐TO‐HEAD COMPARISON OF PIB AND FDG‐PET IN AUTOPSY‐CONFIRMED CASES
32. O5‐05‐05: REPURPOSING THE KCA3.1 INHIBITOR SENICAPOC AS A MICROGLIA‐TARGETED THERAPEUTIC CANDIDATE FOR ALZHEIMER'S DISEASE
33. P3‐556: NEUROPATHOLOGICAL DIFFERENCES ACROSS THREE ETHNORACIAL GROUPS WITH DEMENTIA
34. Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet–induced systemic inflammation, microglial activation, and reduced neuroplasticity
35. Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke
36. Transethnic genome‐wide scan identifies novel Alzheimer's disease loci
37. Differential Kv1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microglia
38. P1-253: Diagnostic Accuracy of Amyloid- Versus Fdg-Pet in Autopsy-Confirmed Dementia
39. P2‐284: Lipopolysaccharide and E. COLI Proteins and DNA in Alzheimer's Disease Brains Compared to Controls
40. O2-07-05: KV1.3 Inhibition Reduces Ab-Induced Microglial Neurotoxicity
41. P2-285: CENTILOID THRESHOLDS FOR AMYLOID POSITIVITY DERIVED FROM AUTOPSY-PROVEN CASES
42. IC-P-055: Centiloid Thresholds for Amyloid Positivity Derived from Autopsy-Proven Cases
43. THE VOLTAGE‐GATED POTASSIUM CHANNEL KV1.3 AS A TARGET FOR INHIBITING DETRIMENTAL M1 MICROGLIA FUNCTIONS
44. Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP
45. ChemInform Abstract: Syntheses of 3-[(Alkylamino)methylene]-6-methylpyridine-2,4(1H,3H)-diones, 3-Substituted 7-Methyl-2H-pyrano[3,2-c]pyridine-2,5(6H)-dione Fluorescence Probes, and Tetrahydro-1H,9H-2,10-dioxa-9-azaanthracen-1-ones.
46. O1-01-06: COMPARING LIBERAL AND CONSERVATIVE THRESHOLDS FOR AMYLOID PET POSITIVITY IN AUTOPSY-PROVEN CASES
47. O3-14-05: RESTORATION OF AXONAL TRAFFICKING OF MITOCHONDRIA AVERTS COGNITIVE DECLINE IN MOUSE MODELS OF FAMILIAL ALZHEIMER'S DISEASE
48. IC‐P‐011: COMPARING LIBERAL AND CONSERVATIVE THRESHOLDS FOR AMYLOID PET POSITIVITY IN AUTOPSY‐PROVEN CASES
49. Reduced GABAergic synaptic transmission in the nucleus tractus solitarius in Mecp2 ‐null mice (1130.20)
50. Pathology of inherited manganese transporter deficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.